Medical device recalls

Affymetrix Inc recalls CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and an…

Recall date
April 14, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1909-2016
FDA classification
Class III
Brand / firm
Affymetrix Inc
Sold / distributed
Distributed in the US to the states of AR, CA, DC, MI, MA, MN, NC, NM, NY, PA, SC, TN, TX, WA and WV.

Why it was recalled

During a recent Ohio site inspection by the FDA it was discovered that warning statements needed to be included with the product shipment.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

CytoScan¿ Dx Assay. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software. The CytoScan Dx Assay consists of five reagent modules, wash buffers (WS), a microarray kit, and analysis software: MOD R LA, CytoScan¿ Dx Pre-PCR (-20¿C) MOD T E W, CytoScan¿ Dx Pre-PCR (2¿-8¿C) MOD F L H, CytoScan¿ Dx Post-PCR (-20¿C) MOD S AH W PB, CytoScan¿ Dx Post-PCR (2¿-8¿C) MOD E PW, CytoScan¿ Dx Post-PCR (15¿- 30¿ C) CytoScan Dx WS A CytoScan Dx WS B CytoScan¿ Dx Array kit, 6Pk ChAS Dx Analysis Software and Browser

Get recall alerts

Free email alert whenever Affymetrix Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Affymetrix Inc